Clinical Study

Rheumatoid Factor Positivity Is Associated with Increased Joint Destruction and Upregulation of Matrix Metalloproteinase 9 and Cathepsin K Gene Expression in the Peripheral Blood in Rheumatoid Arthritic Patients Treated with Methotrexate

Figure 1

Relative expression of the genes mTOR (a), ULK1 (b), p21 (c), caspase-3 (d), MMP-9 (e), and cathepsin K (f), and TNFα (g) with reference to β-actin determined by real-time PCR analyses in the whole blood of seronegative (RF−) ( ) and seropositive (RF+) ( ) rheumatoid arthritic patients compared with healthy controls (Control) ( ) at baseline (0) and after 24 months of follow-up (24 mo). Control bar is shown as 1.0 as required for relative quantification with the real-time PCR protocol. Asterisks indicate significant differences from the control in pairwise comparisons (Mann-Whitney test). Number sign (#) shows significant difference from the baseline value (Wilcoxon matched pairs test). & sign indicates significant difference between seronegative and seropositive RA patients (Mann-Whitney test).
457876.fig.001a
(a)
457876.fig.001b
(b)
457876.fig.001c
(c)
457876.fig.001d
(d)
457876.fig.001e
(e)
457876.fig.001f
(f)
457876.fig.001g
(g)